FX Shoulder Solutions Retrospective / Prospective Clinical Study
Launched by FX SHOULDER SOLUTIONS · Oct 4, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
The FX Shoulder Solutions clinical trial is studying the effectiveness of shoulder replacement devices made by FX Shoulder Solutions. This trial aims to learn more about how these devices help patients with conditions like rotator cuff syndrome, osteoarthritis of the shoulder, and shoulder fractures. If you have received one of these shoulder replacement devices between January 1, 2018, and June 30, 2023, you might be eligible to participate in this study.
Participants in this trial will be asked to share their experiences and outcomes after having the shoulder replacement surgery. The study is currently recruiting individuals of all ages and genders who meet the criteria. If you qualify, your involvement will help researchers gain valuable insights into the benefits and effectiveness of these shoulder devices, which can improve treatment for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Received an FX Shoulder Solutions replacement medical device in accordance with the Indications for Use based upon surgeons' determination and standard of care for the selected device system beginning January 1, 2018, through June 30, 2023.
- Exclusion Criteria:
- • Patient who does not meet the inclusion criteria above
About Fx Shoulder Solutions
fx shoulder solutions is a leading clinical trial sponsor dedicated to advancing innovative treatments for shoulder-related conditions. With a strong focus on evidence-based practices, the organization collaborates with healthcare professionals and research institutions to develop and evaluate cutting-edge therapies that enhance patient outcomes. By prioritizing rigorous clinical research and patient safety, fx shoulder solutions aims to address unmet medical needs in orthopedics, ultimately improving the quality of life for individuals suffering from shoulder ailments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gilbert, Arizona, United States
The Villages, Florida, United States
Patients applied
Trial Officials
Brian Rogers, BS
Study Director
FX Shoulder Solutions
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported